Hepatocellular carcinoma and the art of prognostication

被引：16

作者：

Johnson, P

Bruix, J

机构：

[1] Univ Barcelona, Hosp Clin & Prov, BCLC Grp, Liver Unit,Inst Invest Biomed August Pi & Sunyer, Barcelona 08036, Catalonia, Spain

[2] Chinese Univ Hong Kong, Dept Clin Oncol, Prince Wales Hosp, Fac Med, Shatin, Hong Kong, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2000年 / 33卷 / 06期

关键词：

D O I：

10.1016/S0168-8278(00)80137-3

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1006 / 1008

页数：3

共 25 条

[1] NM23-H1 EXPRESSION AND DISEASE RECURRENCE AFTER SURGICAL RESECTION OF SMALL HEPATOCELLULAR-CARCINOMA [J].

BOIX, L ;

BRUIX, J ;

CAMPO, E ;

SOLE, M ;

CASTELLS, A ;

FUSTER, J ;

RIVERA, F ;

CARDESA, A ;

RODES, J .

GASTROENTEROLOGY, 1994, 107 (02) :486-491

[2] PROGNOSTIC FACTORS OF HEPATOCELLULAR-CARCINOMA IN THE WEST - A MULTIVARIATE-ANALYSIS IN 206 PATIENTS [J].

CALVET, X ;

BRUIX, J ;

GINES, P ;

BRU, C ;

SOLE, M ;

VILANA, R ;

RODES, J .

HEPATOLOGY, 1990, 12 (04) :753-760

[3] A new prognostic classification for predicting survival in patients with hepatocellular carcinoma [J].

Chevret, S ;

Trinchet, JC ;

Mathieu, D ;

Rached, AA ;

Beaugrand, M ;

Chastang, C .

JOURNAL OF HEPATOLOGY, 1999, 31 (01) :133-141

[4] Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy [J].

Hui, AM ;

Takayama, T ;

Sano, K ;

Kubota, K ;

Akahane, M ;

Ohtomo, K ;

Makuuchi, M .

JOURNAL OF HEPATOLOGY, 2000, 33 (06) :975-979

[5] Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer [J].

Ikeda, K ;

Arase, Y ;

Saitoh, S ;

Kobayashi, M ;

Suzuki, Y ;

Suzuki, F ;

Tsubota, A ;

Chayama, K ;

Murashima, N ;

Kumada, H .

HEPATOLOGY, 2000, 32 (02) :228-232

[6]

*INT UN CANC UICC, 1997, TNM CLASS MAL TUM, P74

[7] TRIMETHADIONE TOLERANCE-TESTS FOR THE ASSESSMENT OF FEASIBLE SIZE OF HEPATIC RESECTION IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA [J].

ISHIKAWA, A ;

FUKAO, K ;

TSUJI, K ;

OSADA, A ;

YAMAMOTO, Y ;

OHTSUKA, M ;

TANAKA, E .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1993, 8 (05) :426-432

[8] PROGNOSTIC FACTORS OF HEPATOCELLULAR-CARCINOMA IN PATIENTS UNDERGOING HEPATIC RESECTION [J].

IZUMI, R ;

SHIMIZU, K ;

II, T ;

YAGI, M ;

MATSUI, O ;

NONOMURA, A ;

MIYAZAKI, I .

GASTROENTEROLOGY, 1994, 106 (03) :720-727

[9] Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial [J].

Lau, WY ;

Leung, TWT ;

Ho, SKW ;

Chan, M ;

Machin, D ;

Lau, J ;

Chan, ATC ;

Yeo, W ;

Mok, TSK ;

Yu, SCH ;

Leung, NWY ;

Johnson, PJ .

LANCET, 1999, 353 (9155) :797-801

[10] Natural history of untreated nonsurgical hepatocellular carcinoma:: Rationale for the design and evaluation of therapeutic trials [J].

Llovet, JM ;

Bustamante, J ;

Castells, A ;

Vilana, R ;

Ayuso, MD ;

Sala, M ;

Brú, C ;

Rodés, J ;

Bruix, J .

HEPATOLOGY, 1999, 29 (01) :62-67

← 1 2 3 →